In a 30-year-old woman with a 2‑cm endometrial polyp, is there any conservative (non‑surgical) management option?

Conservative Management of Endometrial Polyps

Yes, conservative (expectant) management is a valid option for asymptomatic endometrial polyps, particularly those <10 mm in size, with approximately 25% regressing spontaneously 1, 2. However, in a 30-year-old woman with a 2-cm polyp, the decision depends critically on symptoms, fertility goals, and malignancy risk factors.

Algorithm for Conservative vs. Surgical Management

Asymptomatic Premenopausal Women (like your 30-year-old patient):

• Polyps <10 mm: Conservative management is safe with structured ultrasound surveillance at 3 months, 9 months, then annually 3

  • Spontaneous regression occurs in 14.5% of premenopausal women 3
  • Overall regression rate across all sizes is 8-25% 4, 2

• Polyps ≥10 mm (your 2-cm case): The evidence becomes more nuanced

  • If truly asymptomatic AND no fertility concerns: Conservative management remains an option with close surveillance 3
  • Larger polyps have lower spontaneous regression rates and higher likelihood of requiring eventual excision 3
  • Larger baseline diameter (per 5 mm increase) independently predicts earlier need for surgical excision (HR 1.22,95% CI 1.06-1.41) 3

When Conservative Management is NOT Appropriate:

Polypectomy is mandatory in these scenarios 1:

• Any abnormal uterine bleeding (most common indication for surgery)
• Subfertility/infertility: Hysteroscopic polypectomy improves fertility outcomes significantly
  • RR 2.1 (95% CI 1.5-2.9) for pregnancy after polypectomy before IUI 5
  • Clinical pregnancy rates 53-72% and live birth rates 43-66% after polypectomy in IVF/ICSI 5
• Postmenopausal status (higher malignancy risk ~3% overall, increases with age) 4, 2
• High vascularity on ultrasound (color score ≥3 predicts earlier excision need, HR 1.85) 3

Critical Pitfalls to Avoid

The 2-cm size in your case is important: While conservative management is technically possible for asymptomatic premenopausal women regardless of size 3, a 2-cm polyp:

• Has lower likelihood of spontaneous regression
• Mechanically may interfere with fertility even if asymptomatic now 6, 5
• Requires more vigilant surveillance

If she desires pregnancy in the near future, polypectomy should be strongly recommended rather than conservative management, as polyps at fundal/tubocornual regions mechanically affect fertility and cause chronic inflammation that disrupts normal cellular function 6.

Surveillance Protocol for Conservative Management

If conservative management is chosen 3:

• Transvaginal ultrasound at 3 months, 9 months, then annually
• Document size, vascularity (IETA standards), and any interval symptoms
• Threshold for intervention: development of AUB (occurs in 8.7% during surveillance), polyp growth, or patient preference

Medical Treatment Options

There is no proven preventative or medical treatment for complete polyp resolution 4. However:

• Levonorgestrel-IUS and progesterone may reduce recurrence risk post-polypectomy 7
• Medical therapy alone is not recommended as primary treatment for existing polyps

Malignancy Risk Context

The overall malignancy risk is low (~1-3%) 4, 2, and in the recent 2026 study of expectant management, only 1/96 excised polyps (1.04%) showed carcinoma 3. In a 30-year-old without postmenopausal bleeding, malignancy risk is extremely low, making conservative management safer from an oncologic standpoint compared to older women.

For your specific 30-year-old with a 2-cm asymptomatic polyp: Conservative management with structured surveillance is acceptable if she has no fertility concerns and remains truly asymptomatic, but hysteroscopic polypectomy should be strongly considered given the size and low spontaneous regression likelihood 3.